Aspira Women'S Health INC. (AWHL) — 10-Q Filings

10-Q Filings (6)

• Aspira Women's Health Narrows 9-Month Loss Amidst Delisting, Liquidity Woes — Nov 14, 2025 Risk: high
  Aspira Women's Health Inc. (AWHL) reported a net loss of $4.892 million for the three months ended September 30, 2025, an increase from $3.547 million in the pr
• Aspira Women's Health Narrows Losses Amidst Cost Cuts — Aug 13, 2025 Risk: high
  Aspira Women's Health Inc. (AWHL) reported a net loss of $2.666 million for the three months ended June 30, 2025, an improvement from the $3.530 million net los
• Aspira Women's Health Files Q1 2025 10-Q — May 19, 2025 Risk: low
  Aspira Women's Health Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Vermillion, Inc., is involved in in vitro & in vi
• Aspira Women's Health Files Q3 2024 10-Q — Nov 19, 2024 Risk: medium
  Aspira Women's Health Inc. filed a 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal ye
• Aspira Women's Health Files Q2 10-Q, Details Stock Offerings — Aug 13, 2024 Risk: medium
  Aspira Women's Health Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial performance and business activities, includ
• Aspira Women's Health Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk:
  Aspira Women's Health Inc. (AWHL) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Aspira Women's Health Inc. filed a 10-Q report for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX